EPIDERMAL GROWTH-FACTOR INDUCES THE FUNCTIONAL EXPRESSION OF DOPAMINE-RECEPTORS IN THE GH3 CELL-LINE

被引:59
作者
MISSALE, C
CASTELLETTI, L
BORONI, F
MEMO, M
SPANO, P
机构
[1] Inst. Pharmacol. and Exp. Therapeut., School of Medicine, University of Brescia
[2] Inst. Pharmacol. and Exp. Therapeut., School of Medicine, University of Brescia, 25124 Brescia
关键词
D O I
10.1210/endo-128-1-13
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
GH3 cells are a clonal strain from a rat pituitary tumor that synthesizes and secretes both PRL and GH. The peculiarity of these cells is that they do not express receptors for dopamine; thus the hormone release is insensitive to the inhibitory effect of dopamine and D2 receptor agonists. Exposure of GH3 cells to epidermal growth factor for 4 consecutive days markedly altered the cell morphology, from a spherical appearance to an elongated flattened shape, and increased the cell size. These morphological changes were accompanied by the functional expression of D2 dopamine receptors as shown by the presence of a specific, saturable, and stereoselective high affinity binding for [H-3] spiroperidol in epidermal growth factor-treated cells and by the fact that the selective D2 agonist quinpirole recovered the property to inhibit PRL secretion in the cell cultures exposed to the neurotrophic factor. The effect of EGF on the functional expression of D2 receptors was dose dependent (EC50 = 8 pM) and reversible. These data suggest that EGF elicits major effects on the expression of specific genes leading to the differentiation of GH3 cells into lactotroph-like cells endowed with dopamine D2 receptors.
引用
收藏
页码:13 / 20
页数:8
相关论文
共 35 条
  • [1] [Anonymous], FRONT NEUROENDOCRIN
  • [2] BANG S, 1977, ACTA PHARMACOL TOX, V41, P317
  • [3] ABNORMAL PROLACTIN RESPONSIVITY TO DOPAMINERGIC SUPPRESSION IN HYPERPROLACTINEMIC PATIENTS
    BANSAL, S
    LEE, LA
    WOOLF, PD
    [J]. AMERICAN JOURNAL OF MEDICINE, 1981, 71 (06) : 961 - 966
  • [4] CARON MG, 1978, J BIOL CHEM, V253, P2244
  • [5] EPIDERMAL GROWTH-FACTOR
    CARPENTER, G
    COHEN, S
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1979, 48 : 193 - 216
  • [6] POTASSIUM CHANNELS INVOLVED IN THE TRANSDUCTION MECHANISM OF DOPAMINE-D2 RECEPTORS IN RAT LACTOTROPHS
    CASTELLETTI, L
    MEMO, M
    MISSALE, C
    SPANO, PF
    VALERIO, A
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 1989, 410 : 251 - 265
  • [7] CONTROL OF A CELL-SURFACE MAJOR GLYCOPROTEIN BY EPIDERMAL GROWTH-FACTOR
    CHEN, LB
    GUDOR, RC
    SUN, TT
    CHEN, AB
    MOSESSON, MW
    [J]. SCIENCE, 1977, 197 (4305) : 776 - 778
  • [8] ABSENCE OF HIGH-AFFINITY DOPAMINE-RECEPTORS IN GH3 CELLS - PROLACTIN-SECRETING CLONE RESISTANT TO THE INHIBITORY-ACTION OF DOPAMINE
    CRONIN, MJ
    FAURE, N
    MARTIAL, JA
    WEINER, RI
    [J]. ENDOCRINOLOGY, 1980, 106 (03) : 718 - 723
  • [9] EFFECT OF CENTRAL NERVOUS-SYSTEM DOPAMINERGIC ACTIVATION ON PROLACTIN SECRETION IN MAN - EVIDENCE FOR A COMMON CENTRAL DEFECT IN HYPERPROLACTINEMIC PATIENTS WITH AND WITHOUT RADIOLOGICAL SIGNS OF PITUITARY-TUMORS
    CROSIGNANI, PG
    FERRARI, C
    MALINVERNI, A
    BARBIERI, C
    MATTEI, AM
    CALDARA, R
    ROCCHETTI, M
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1980, 51 (05) : 1068 - 1073
  • [10] DOPAMINE INHIBITS ADENYLATE-CYCLASE IN HUMAN PROLACTIN-SECRETING PITUITARY ADENOMAS
    DECAMILLI, P
    MACCONI, D
    SPADA, A
    [J]. NATURE, 1979, 278 (5701) : 252 - 254